US Map / Missouri
State MO

Clinical Trials in Missouri

Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.

Total Trials
296
Recruiting Now
296
← Back to US Map
Top Conditions in Missouri
Multiple Myeloma (8)Advanced Solid Tumor (7)Breast Cancer (7)Obesity (5)Colorectal Cancer (5)Prostate Cancer (5)Asthma (4)Stage IVB Prostate Cancer AJCC v8 (4)Acute Ischemic Stroke (3)Advanced Solid Tumors (3)Neuroblastoma (3)Chronic Lymphocytic Leukemia (3)

Frequently Asked Questions — Clinical Trials in Missouri

How many clinical trials are currently recruiting in Missouri?
ClinicalMetric currently tracks 296 actively recruiting clinical trials with at least one location in Missouri. The total number of registered studies—including active but not currently enrolling trials—is 296. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Missouri?
Missouri hosts clinical trials across a broad range of medical conditions, including Multiple Myeloma, Advanced Solid Tumor, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Missouri serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Missouri?
To join a clinical trial in Missouri, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Missouri maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Missouri

NCT06926868 Phase 2, Phase 3
Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Prev...
Condition
Breast Neoplasms
Enrollment
500 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT05555589 Phase 3
Recruiting
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for th...
Condition
Neurotrophic Keratopathy
Enrollment
70 pts
Location
United States, Italy, Poland
Sponsor
ReGenTree, LLC
View Trial →
NCT06777823 N/A
Recruiting
Rejection Sensitivity and Puberty in Mental Health Vulnerability to Social Media...
Condition
Rejection Sensitivity
Enrollment
250 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT04647227 Phase 4
Recruiting
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Condition
Hemophilia A With Inhibitor
Enrollment
55 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT05096481 Phase 2
Recruiting
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and...
Condition
High Grade Glioma
Enrollment
120 pts
Location
United States
Sponsor
Nationwide Children's Hospital
View Trial →
NCT05303519 Phase 3
Recruiting
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Condition
Glioma
Enrollment
365 pts
Location
United States, Australia, China
Sponsor
Nuvation Bio Inc.
View Trial →
NCT05907629 N/A
Recruiting
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vasc...
Condition
Stroke
Enrollment
300 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT07200102 Phase 1
Recruiting
Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
Condition
Multiple Myeloma
Enrollment
20 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT05703672 Phase 3
Recruiting
Switching to E-cigarettes in Smokers Not Interested in Quitting
Condition
Smoking Reduction
Enrollment
500 pts
Location
United States
Sponsor
University of Kansas Medical C
View Trial →
NCT07026877 N/A
Recruiting
Endovascular Repair With Fenestrated TREO Stent-Graft System in AAA
Condition
Abdominal Aortic Aneurysms (AAA)
Enrollment
20 pts
Location
United States
Sponsor
Bolton Medical
View Trial →
NCT06034002 Phase 1
Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination W...
Condition
Myeloproliferative Neoplasms
Enrollment
290 pts
Location
United States
Sponsor
Incyte Corporation
View Trial →
NCT07288138 Phase 2
Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicar...
Condition
Metabolic Dysfunction-associated Steatohepatitis
Enrollment
160 pts
Location
United States
Sponsor
Eccogene
View Trial →
NCT07218133 N/A
Recruiting
Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery
Condition
Spinal Fusion
Enrollment
50 pts
Location
United States
Sponsor
Alexander T. Yahanda
View Trial →
NCT06812078 Phase 2
Recruiting
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
Condition
Idiopathic Hypersomnia
Enrollment
96 pts
Location
United States, France, Hong Kong
Sponsor
Takeda
View Trial →
NCT05869955 Phase 1
Recruiting
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Seve...
Condition
Systemic Lupus Erythematosus
Enrollment
270 pts
Location
United States, Belgium, France
Sponsor
Juno Therapeutics, Inc., a Bri
View Trial →
NCT06725758 Phase 1, Phase 2
Recruiting
A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced ...
Condition
Solid Tumours
Enrollment
315 pts
Location
United States, Finland, France
Sponsor
Orion Corporation, Orion Pharm
View Trial →
NCT06931340 Phase 3
Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormona...
Condition
Castration-Sensitive Prostate Carcinoma
Enrollment
1,260 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT04634552 Phase 2
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myel...
Condition
Hematological Malignancies
Enrollment
510 pts
Location
United States, Belgium, China
Sponsor
Janssen Research & Development
View Trial →
NCT03949855 Phase 2
Recruiting
Belimumab With Rituximab for Primary Membranous Nephropathy
Condition
Membranous Nephropathy
Enrollment
58 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT05145491 N/A
Recruiting
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
Condition
Epiretinal Membrane
Enrollment
400 pts
Location
United States, United Kingdom
Sponsor
Jaeb Center for Health Researc
View Trial →
NCT06012240 Phase 3
Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adul...
Condition
Alopecia Areata
Enrollment
1,500 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
View Trial →
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04174157 N/A
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Condition
Spinal Muscular Atrophy (SMA)
Enrollment
700 pts
Location
United States, Greece, Ireland
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07166094 Phase 3
Recruiting
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Inves...
Condition
Endometrial Cancer
Enrollment
660 pts
Location
United States, Australia, Belgium
Sponsor
Genmab
View Trial →
NCT06649812 Phase 2
Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients...
Condition
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
Enrollment
120 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
Page 3 of 12 — 296 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology